Recent Headlines in the IP World:
- Dave Smith: Apple is Exploring an Updated Version of MagSafe, One of Its Best Charging Inventions Ever (Source: Bloomberg)
- Jim Payne: dynaCERT Patent Granted (Source: Associated Press)
- Frederic Lardinois: Microsoft Gives 500 Patents to Startups (Source: Tech Crunch)
- Vlad Savov: LG Patents a Transparent Foldable Phone (Source: The Verge)
Commentary and Journal Articles:
- Prof. Paul R. Gugliuzza: Rising Confusion About ‘Arising Under’ Jurisdiction in Patent Cases (Source: SSRN)
- Malathi Nayak: Tillis, Coons Vet Patent Eligibility Bill Principles with Stakeholders (Source: Bloomberg Law)
- Joe Nocera: Why Big Pharma Is Winning the Drug Price Wars (Source: Bloomberg)
New Job Postings on Patently-O:
- Christensen O’Connor Johnson Kindness PLLC
- Klein, O’Neill & Singh, LLP
- Sheridan Ross P.C.
- Duane Morris LLP
- Banjo
- Intellectual Property Owners Association
- Klarquist Sparkman, LLP–Patent Attorney
- Klarquist Sparkman, LLP–Patent Attorney
- Klarquist Sparkman, LLP–Patent Attorney
- Klarquist Sparkman, LLP–Litigation Associate
- Buchanan Ingersoll & Rooney PC
If you read the Joe Nocera piece, it is an interview with Robin Feldman. As it happens, Dr. Feldman recently made an appearance on Russ Roberts’ Econtalk podcast. Her talk with Roberts and her interview with Nocera are largely the same.
Having both read the Nocera interview, and listened to the Roberts podcast, I do not really disagree with Dr. Feldman about the problematic nature of the price growth of certain pharmaceuticals (especially generic pharmaceuticals). I do question, however, her proposed solutions that go after patents in the pharma industry. By her own admission, prices are also going up faster than inflation with regard to certain long-since-off-patent drugs like insulin. This should tell you that the problem here is not really caused by patents.
Rather, the holdup is in FDA law. If she really wants to solve the problem, she would do better to suggest changes to FDA law than to patent law.
Comments are closed.